These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9090310)

  • 1. Pharmacological criteria for the detection of beta 3-adrenoceptors.
    De Ponti F
    Trends Pharmacol Sci; 1997 Feb; 18(2):52-3. PubMed ID: 9090310
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological properties of beta 3-adrenoceptors.
    Nisoli E; Carruba MO
    Trends Pharmacol Sci; 1997 Jul; 18(7):257-8. PubMed ID: 9253858
    [No Abstract]   [Full Text] [Related]  

  • 3. [Beta 3-receptors: incidence and properties, possible clinical significance].
    Gullestad L; Osnes JB
    Tidsskr Nor Laegeforen; 1995 Jan; 115(1):45-9. PubMed ID: 7846660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta 3-adrenoceptors and intestinal motility.
    Manara L; Croci T; Landi M
    Fundam Clin Pharmacol; 1995; 9(4):332-42. PubMed ID: 8566932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characteristics and species-related variations of beta 3-adrenergic receptors.
    Pietri-Rouxel F; Strosberg AD
    Fundam Clin Pharmacol; 1995; 9(3):211-8. PubMed ID: 7557816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta1-adrenergic receptors mediate beta3-adrenergic-independent effects of CGP 12177 in brown adipose tissue.
    Konkar AA; Zhai Y; Granneman JG
    Mol Pharmacol; 2000 Feb; 57(2):252-8. PubMed ID: 10648634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro selectivity of agonists and antagonists for beta 1- and beta 2-adrenoceptor subtypes in rat brain.
    Beer M; Richardson A; Poat J; Iversen LL; Stahl SM
    Biochem Pharmacol; 1988 Mar; 37(6):1145-51. PubMed ID: 2895652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-obesity and anti-diabetic activities of a new beta3 adrenergic receptor agonist, (S)-(Z)-[4-[[1-[2-[(2-hydroxy-3-phenoxypropyl)]amino]ethyl]-1-propenyl] phenoxy] acetic acid ethanedioic acid (SWR-0342SA), in KK-Ay mice.
    Kiso T; Namikawa T; Tokunaga T; Sawada K; Kakita T; Shogaki T; Ohtsubo Y
    Biol Pharm Bull; 1999 Oct; 22(10):1073-8. PubMed ID: 10549858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha- and beta-adrenoceptors: from the gene to the clinic. 2. Structure-activity relationships and therapeutic applications.
    Ruffolo RR; Bondinell W; Hieble JP
    J Med Chem; 1995 Sep; 38(19):3681-716. PubMed ID: 7562902
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of pharmacological and binding assays for ten beta-adrenoceptor blocking agents and two beta-adrenoceptor agonists.
    Bieth N; Rouot B; Schwartz J; Velly J
    Br J Pharmacol; 1980 Mar; 68(3):563-9. PubMed ID: 6132636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of beta 1- and beta 3-adrenoceptors in intact brown adipocytes of the rat.
    D'Allaire F; Atgié C; Mauriège P; Simard PM; Bukowiecki LJ
    Br J Pharmacol; 1995 Jan; 114(2):275-82. PubMed ID: 7881727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermodynamics of agonist and antagonist interactions with mammalian beta-adrenergic receptors.
    Weiland GA; Minneman KP; Molinoff PB
    Mol Pharmacol; 1980 Nov; 18(3):341-7. PubMed ID: 6110167
    [No Abstract]   [Full Text] [Related]  

  • 13. Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells.
    Carpéné C; Galitzky J; Fontana E; Atgié C; Lafontan M; Berlan M
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):310-21. PubMed ID: 10344530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental studies with selective beta-adrenergic agonists and antagonists in animals.
    Stock MJ
    Int J Obes Relat Metab Disord; 1993 Dec; 17 Suppl 3():S69-72; discussion S82. PubMed ID: 7907258
    [No Abstract]   [Full Text] [Related]  

  • 15. The pharmacological specificity of beta-1 and beta-2 adrenergic receptors in rat heart and lung in vitro.
    Minneman KP; Hegstrand LR; Molinoff PB
    Mol Pharmacol; 1979 Jul; 16(1):21-33. PubMed ID: 39243
    [No Abstract]   [Full Text] [Related]  

  • 16. Characteristics of 125I-iodocyanopindolol binding to beta-adrenergic and serotonin-1B receptors of rat brain: selectivity of beta-adrenergic agents.
    Tsuchihashi H; Nakashima Y; Kinami J; Nagatomo T
    Jpn J Pharmacol; 1990 Feb; 52(2):195-200. PubMed ID: 1968985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical responses of rat ileum to pindolol, cyanopindolol and iodocyanopindolol.
    Hoey A; Jackson C; Pegg G; Sillence M
    Br J Pharmacol; 1996 Feb; 117(4):712-6. PubMed ID: 8646418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pharmacology of human beta-adrenergic receptor subtypes--characterization of stably transfected receptors in CHO cells.
    Hoffmann C; Leitz MR; Oberdorf-Maass S; Lohse MJ; Klotz KN
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Feb; 369(2):151-9. PubMed ID: 14730417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mediation of most atypical effects by species homologues of the beta 3-adrenoceptor.
    Blin N; Nahmias C; Drumare MF; Strosberg AD
    Br J Pharmacol; 1994 Jul; 112(3):911-9. PubMed ID: 7921620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LK 204-545, a highly selective beta1-adrenoceptor antagonist at human beta-adrenoceptors.
    Louis SN; Nero TL; Iakovidis D; Jackman GP; Louis WJ
    Eur J Pharmacol; 1999 Feb; 367(2-3):431-5. PubMed ID: 10079020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.